Liang T, Heiss C E, Cheung A H, Reynolds G F, Rasmusson G H
J Biol Chem. 1984 Jan 25;259(2):734-9.
In efforts to develop potent 5 alpha-reductase inhibitors without affinity for the androgen receptor, synthetic 3-oxo-5 alpha-steroids were tested for their ability to inhibit 5 alpha-reductase, using [14C]testosterone as the substrate, and for their ability to inhibit the binding of [3H]5 alpha-dihydrotestosterone to the androgen receptor of rat prostate cytosol. 2',3' alpha-Tetrahydrofuran-2'-spiro-17-(5 alpha-androstan-3-one) is not an inhibitor of 5 alpha-reductase and has a high affinity for the androgen receptor; substitution of the -CH2- at the 4-position with N-H resulted in a good inhibitor of 5 alpha-reductase. The 4-N-CH3 derivative is even more active, whereas the N-CH2-CH3 derivative is inactive. These 4-aza derivatives have much lower affinity for the androgen receptor than the parent compound. The 4-N-H derivatives of several 3-oxo-5 alpha-steroids were found to be 20-100% as potent as their corresponding 4-N-CH3 analogs as inhibitors of 5 alpha-reductase, whereas their androgen receptor affinities were at least 40-fold lower than their 4-N-CH3 analogs. Their 5 beta-isomers did not inhibit either 5 alpha-reductase or the androgen receptor binding of [3H]5 alpha-dihydrotestosterone. Two of these 4-N-H steroids, 17 beta-N,N-diethylcarbamoyl-4-aza-5 alpha-androstan-3-one and 17 beta-N, N-diisopropylcarbamoyl-4-aza-5 alpha-androstan-3-one, are potent 5 alpha-reductase inhibitors with Ki values equal to 29.2 +/- 1.7 and 12.6 +/- 0.8 nM, respectively, but have little affinity for the androgen receptor. The inhibition of 5 alpha-reductase by both compounds is competitive with testosterone. When [3H]testosterone was incubated with minced rat prostate in the presence of either of these two 4-azasteroids, the nuclear concentration of 5 alpha-dihydrotestosterone decreased and that of testosterone increased. The total nuclear uptake of testosterone plus 5 alpha-dihydrotestosterone was not significantly affected. These 4-azasteroids should be useful for investigating the importance of 5 alpha-reductase in androgen action in vivo.
为了开发对雄激素受体无亲和力的强效5α-还原酶抑制剂,以[14C]睾酮为底物,测试了合成的3-氧代-5α-甾体抑制5α-还原酶的能力,以及它们抑制[3H]5α-二氢睾酮与大鼠前列腺细胞质雄激素受体结合的能力。2',3'α-四氢呋喃-2'-螺-17-(5α-雄甾烷-3-酮)不是5α-还原酶的抑制剂,对雄激素受体具有高亲和力;4位的-CH2-被N-H取代后得到了一种良好的5α-还原酶抑制剂。4-N-CH3衍生物活性更高,而N-CH2-CH3衍生物无活性。这些4-氮杂衍生物对雄激素受体的亲和力远低于母体化合物。发现几种3-氧代-5α-甾体的4-N-H衍生物作为5α-还原酶抑制剂的效力是其相应4-N-CH3类似物的20%-100%,而它们对雄激素受体的亲和力比对4-N-CH3类似物至少低40倍。它们的5β-异构体既不抑制5α-还原酶,也不抑制[3H]5α-二氢睾酮与雄激素受体的结合。其中两种4-N-H甾体,17β-N,N-二乙基氨基甲酰基-4-氮杂-5α-雄甾烷-3-酮和17β-N,N-二异丙基氨基甲酰基-4-氮杂-5α-雄甾烷-3-酮,是强效的5α-还原酶抑制剂,Ki值分别等于29.2±1.7和12.6±0.8 nM,但对雄激素受体几乎没有亲和力。两种化合物对5α-还原酶的抑制作用与睾酮竞争。当[3H]睾酮与切碎的大鼠前列腺在这两种4-氮杂甾体中的任何一种存在下孵育时,5α-二氢睾酮的核浓度降低,睾酮的核浓度升高。睾酮加5α-二氢睾酮的总核摄取量没有受到显著影响。这些4-氮杂甾体应该有助于研究5α-还原酶在体内雄激素作用中的重要性。